GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Sale Of Investment

Apollomics (Apollomics) Sale Of Investment : $20.49 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Sale Of Investment?

Apollomics's sale of investment for the six months ended in Dec. 2023 was $16.18 Mil. It means Apollomics gained $16.18 Mil from selling investments. Apollomics's sale of investment for the trailing twelve months (TTM) ended in Dec. 2023 was $20.49 Mil.

Compared with last quarter ($4.31 Mil in Jun. 2023 ), Apollomics gained more money from selling investments in Dec. 2023 ($16.18 Mil).

Apollomics Sale Of Investment Historical Data

The historical data trend for Apollomics's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Sale Of Investment Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Sale Of Investment
18.00 71.95 29.00 20.49

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Sale Of Investment Get a 7-Day Free Trial 65.40 24.00 5.00 4.31 16.18

Apollomics Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $20.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apollomics Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Apollomics's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollomics (Apollomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Sale Of Investment
Comparable Companies
ATHA STTK ACXP CARA TLSA ORMP IMMX CCCC GTHX GBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
APLM:USA
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Website
https://www.apollomicsinc.com
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.